Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 69.43M
46.78x6.24x-0.75x - - - 2.56% 313B
24.1x2.03x-19.41x3.31x11.79x19.29x1.63% 70.89B
12x12.7x0.07x6.08x9.36x10.28x - 9.58B
17.78x1.53x0.88x2.28x7.82x9.34x2.51% 8.82B
36.73x - 0.24x6.93x19.8x32.08x - 4.25B
22.41x5.96x2.25x6.37x18.02x18.84x-.--% 4.29B
38.64x2.3x-1.26x2.19x26.93x40.66x0.8% 3.39B
109.02x - -0.67x - - - -.--% 2.74B
17.14x0.75x-0.62x1.34x23.94x40.98x4.13% 1.05B
52.56x - -0.1x - - - - 1.04B
-7.23x11.91x0.46x197.88x-6.41x-5x-.--% 938M
Average 33.63x 5.43x -1.72x 28.30x 13.91x 20.81x 1.45% 35.02B
Weighted average by Cap. 41.36x 5.53x -3.80x 5.46x 12.27x 18.81x 2.33%
Specialty & Advanced Pharmaceuticals